Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-10 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |